Skip to content

How are the methods implemented outside of the domain they are designed for? #101

Description

@jasperhyp

For example, DeepSynergy and MatchMaker are requiring cell line information, and they are both implemented in the DrugBankDDI & TWOSIDES benchmarks where no cell line information is available at all (and TWOSIDES is even at the patient level), with DS reaching the highest performance among all methods. What then was the "cell line gene expression" component in both methods replaced within those tasks? Also, does this ensure a fair comparison?

Metadata

Metadata

Assignees

No one assigned

    Labels

    No labels
    No labels

    Type

    No type

    Fields

    No fields configured for issues without a type.

    Projects

    No projects

    Milestone

    No milestone

    Relationships

    None yet

    Development

    No branches or pull requests

    Issue actions